The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.125
Bid: 6.75
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.75 (11.111%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 7.00
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Persimmon Leads Housebuilders Higher

Tue, 21st Aug 2018 10:44

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Persimmon, up 1.3%. The housebuilder said it continued to deliver on its long-term strategy after recording a rise in first half profit and revenue. For the six months to the end of June, pretax profit totaled GBP516.5 million, up 13% from GBP457.4 million the year before, as revenue grew 5% to GBP1.84 billion from GBP1.75 billion. Persimmon said it sold 8,402 homes during the period, up from 7,794 the prior year, with the average selling price of those homes standing at GBP215,813, up 1.2% from GBP213,262. Fellow housebuilders Berkeley Group, Barratt Developments and Taylor Wimpey were up 0.8%, 0.7% and 0.5% respectively. WM Morrison Supermarkets, up 0.9% and Ocado, up 0.5%. Morrisons regained the position of fastest growing - which it had lost to Asda last month - with sales up 2.7% and market share flat at 10.4% according to data from Kantar Worldpanel. Ocado saw sales up 8.5%, as it increased its market share to 1.2% from 1.1% recorded in the year ago period. Kantar - reporting market share figures for the 12 weeks to August 12 - said branded products sales increased 3.9%, overtaking the total growth of supermarket-owned products for the first time since May 2015.----------FTSE 100 - LOSERS----------BHP Billiton, down 1.3%. The Anglo-Australian miner paid out to shareholders above its policy level, with annual profit rising though short of consensus. The total dividend for BHP's financial year was 118 cents, far higher than the 83 cents paid out a year earlier and above analyst consensus of a 116 cents return. BHP's pretax profit rose to USD14.75 billion from USD11.14 billion the prior year, while underlying earnings before interest, tax, depreciation, and amortisation was up 20% to USD23.18 billion. This excludes US shale operations, since sold off to BP, and falls short of analyst consensus of USD24.31 billion underlying Ebitda. Including US shale, the figure was USD24.11 billion. ----------FTSE 250 - WINNERS----------John Wood Group, up 6.5%. The oilfield services company swung to a loss in the first half of 2018 due to its purchase of Amec Foster Wheeler, in spite of strong revenue growth. The company swung to a pretax loss for the six months to the end of June on a proforma basis of USD25.3 million from a profit of USD13.5 million the year before, due to a one-off cost of USD101.1 million. The loss stemmed from bank fees related to the GBP2.20 billion acquisition of peer Amec Foster Wheeler, which completed in October. However, on an underlying basis, pretax profit rose to USD82.0 million from USD64.2 million. John Wood's revenue saw double digit growth, rising by 13% to USD5.38 billion from USD4.74 billion on a proforma basis the year before, due to growth in the company's Asset Solutions Business with increased capital projects activity.Aggreko, up 5.1%. HSBC upgraded the temporary power generator supplier to Buy from Hold. ----------OTHER MAIN MARKET AND AIM - WINNERS----------IXICO, up 16%. The data science company said it expects 24% jump in annual revenue, ahead of market expectations. For the year ending September 30, the data science company said it now expects revenue to be "at least" GBP5.1 million, up from GBP4.1 million a year ago, reflecting contract wins in the period. "The board expects that this will result in a reduced operating loss for the year," the company added. Looking further ahead, the company said it it confident in meeting market expectations for the year ending Septmebr 2019, as it "continues to invest in its commercially led growth strategy on the path to profitability".Tracsis, up 8.8%. The transport industry software and technology company said it expects annual revenue "ahead of market expectations" after experiencing positive momentum in all parts of the group. For the year to July 31, the company said it expects revenue at GBP40 million, up 16% from GBP34.5 million a year ago. The company added that it expects earnings before interest, taxes, depreciation and amortisation and adjusted profit to be both ahead of market expectations and ahead of the previous year, which had come in at GBP8.5 million and GBP7.7 million respectively.----------OTHER MAIN MARKET AND AIM - LOSERS----------Panthera Resources, down 25%. The gold exploration and development company noted that the government of Rajasthan has rejected the prospecting licence application made for the Bhukia joint venture in India by partner Metal Mines India. The government rejected the application due to finding the reconnaissance permit granted to Metal Mines null and void as the licence application was filed under the name Metal Mining India Ltd but the permit given to Metal Mining India Pvt Ltd. Other reasons for the rejection was a restriction in place for grant in Tibal Areas under a government order in 2000, and because the Geological Survey of India had reserved some of the land, and has expressed intentions to carry out G-2 level exploration. Panthera Resources said its joint venture has an very strong base to launch a legal challenge against the Rajasthan government to deny his rights.----------
More News
17 Jan 2017 08:47

Giulio Cerroni appointed CEO of IXICO

(ShareCast News) - Brain health company IXICO announced on Tuesday that Giulio Cerroni will be appointed to the board as chief executive officer, with effect from 6 February. The AIM-traded firm said Derek Hill, the co-founder and current CEO, will remain on the board and continue to serve as an exe

Read more
16 Nov 2016 10:01

Ixico joins European syndicate to collect data on Alzheimer's

(ShareCast News) - Brain health company Ixico is to receive €100,000 to provide digital technologies for collection and analysis of data , which further expands its work on wearable bio-sensors as part of a pan-European partnership. The AIM-listed company is to participate in a new collaborative EU

Read more
21 Oct 2016 10:15

Ixico's income falls slightly but has a number of contracts in the pipeline

(ShareCast News) - AIM-listed Ixico's income for the year fell, but the brain health company has a number of contracts with pharmaceuticals in the pipeline and a "strong" balance sheet. In trading update for the year ended 30 September, the company reported revenues of £3.1m and other income of £700

Read more
20 Oct 2016 11:01

Ixico pens deal to help develop a therapy for Parkinson's like diesease

(ShareCast News) - Shares in AIM-listed Ixico rose above 22% on Thursday, as the brain health company announced it had signed a $1.2m contract with a global pharmaceutical for imaging clinical trial services for a Parkinson's-like neurodegenerative disease. The project is for a second phase clinical

Read more
10 Oct 2016 12:26

Ixico to receive €1m from EU Alzheimer's project

(ShareCast News) - AIM-listed pharmaceutical Ixico is to receive €1m as a partner in an EU public-private consortium, which has the potential for long-term revenue through the development of diagnostic and disease management technologies for Alzheimer's. Ixico is to work on the Amyloid Imaging to Pr

Read more
2 Jun 2016 16:27

IXICO study joins Dementias Platform

(ShareCast News) - Brain health company IXICO announced on Thursday that its Cygnus study has joined the high-profile Dementias Platform UK (DPUK). The AIM-traded firm described Cygnus as a real-world digital data collection study from people with cognitive impairment and dementia. It said the four

Read more
18 Jan 2016 13:51

Ixico wins four new contracts worth over £3m

(ShareCast News) - Brain health company Ixico was recently awarded four new contracts with "leading" pharmaceutical groups and a specialist biotechnology firm totalling over £3m in value. The contracts involve global clinical trials of novel drugs for Alzheimer's disease spanning three major phases

Read more
19 Oct 2015 12:33

Ixico full-year income in line with expectations

(ShareCast News) - Brain health company Ixico reported revenues for the year of £3.1m and other income at £1m, in line with market expectations and giving a total combined income of £4.1m. This was down from £4.3m for the 16-month period to 30 September 2014. In a pre-close trading update ahead of

Read more
29 Jun 2015 11:11

Ixico secures two clinical trial contracts alongside partner VirtualScopics

Ixico has won two contracts to deploy its products in unnamed pharmaceutical companies' clinical trials, alongside its partner VirtualScopics. Both studies will employ Ixico's TrialTracker digital platform to collect and image data, one pertaining to metastatic solid tumours and the other to rare ne

Read more
17 Sep 2014 08:48

IXICO Appoints CFO For October 1 Start

Read more
21 Jul 2014 15:45

DIRECTOR DEALINGS: IXICO Divisional Vice-President Buys Shares

Read more
18 Jul 2014 07:25

UK MORNING BRIEFING: Shares Lower On Ukraine Crash, Gaza Offensive

Read more
19 Jun 2014 10:40

IXICO Joins Medical Research Council Collaboration For Dementia Drive

LONDON (Alliance News) - IXICO PLC said Thursday it will take part in a GBP16 million collaboration launched by publicly funded government agency the Medical Research Council to speed up research into dementia. The MRC has launched the UK Dementias Research Platform with the aim of seeking

Read more
19 Jun 2014 08:30

Ixico partners with the Medical Research Council to launch UK Dementias Research Platform

Biotechnology group Ixico has partnered with the Medical Research Council (MRC) to launch the UK Dementias Research Platform (UKDP), a £16m public-private partnership. The group, which set up the partnership to speed up research into dementias, will act as the MRC's imaging partner on the project a

Read more
6 Jun 2014 09:20

IXICO To Meet Full-Year Expectations As Interim Hit By Listing Costs

LONDON (Alliance News) - IXICO PLC expressed confidence Friday in meeting market expectations for the full year, as it swung into a loss in the half year to end-March, hit by costs relating to its AIM listing and a decline in revenues. The company was formed via the reverse takeover of Phyt

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.